optiray 350
obex medical ltd - ioversol 74% (provides 35% (350mg/ml) organically bound iodine) - solution for injection - 74 % - active: ioversol 74% (provides 35% (350mg/ml) organically bound iodine) excipient: sodium calcium edetate trometamol
optiray 350 (ultraject) solution
liebel-flarsheim company llc - ioversol - solution - 74% - ioversol 74% - roentgenography
optiray 350- ioversol injection optiray 320- ioversol injection optiray 300- ioversol injection
liebel-flarsheim company llc - ioversol (unii: n3rib7x24k) (ioversol - unii:n3rib7x24k) - ioversol 741 mg in 1 ml - optiray is indicated for: in adults - optiray 300: cerebral arteriography and peripheral arteriography. - optiray 320: cerebral arteriography, peripheral arteriography, visceral and renal arteriography, aortography, coronary arteriography, and left ventriculography. - optiray 350: peripheral arteriography coronary arteriography, and left ventriculography. in pediatric patients - optiray 320 and optiray 350: angiocardiography. in adults - optiray 300: ct imaging of the head and body, venography, and intravenous excretory urography. - optiray 320: ct imaging of the head and body, venography, and intravenous excretory urography. - optiray 350: ct imaging of the head and body, venography, intravenous excretory urography, and intravenous digital subtraction angiography (iv-dsa). - in pediatric patients optiray 320: ct imaging of the head and body, and intravenous excretory urography. symptomatic hyperthyroidism risk summary postmarketing data with optiray use in pregnant women are insufficient to de
optiray 350
obex medical ltd - ioversol 74% (provides 35% (350mg/ml) organically bound iodine.) - solution for injection - 74 % - active: ioversol 74% (provides 35% (350mg/ml) organically bound iodine.) excipient: sodium calcium edetate trometamol
optiray 320mg-ml solution for iv. injection*
liebel flarsheim company llc, united states - ioversol - injection - 350 mg/ml
optiray 350- ioversol injection optiray 320- ioversol injection optiray 300- ioversol injection
liebel-flarsheim company llc - ioversol (unii: n3rib7x24k) (ioversol - unii:n3rib7x24k) - optiray is indicated for: in adults - optiray 300: cerebral arteriography, and peripheral arteriography. - optiray 320: cerebral arteriography, peripheral arteriography, visceral and renal arteriography, aortography, coronary arteriography, and left ventriculography. - optiray 350: peripheral arteriography, coronary arteriography, and left ventriculography. in pediatric patients - optiray 320 and optiray 350: angiocardiography. in adults - optiray 300: ct imaging of the head and body, venography, and intravenous excretory urography. - optiray 320: ct imaging of the head and body, venography, and intravenous excretory urography. - optiray 350: ct imaging of the head and body, venography, intravenous excretory urography, and intravenous digital subtraction angiography (iv-dsa). in pediatric patients - optiray 320: ct imaging of the head and body, and intravenous excretory urography. symptomatic hyperthyroidism. risk summary postmarketing data with optiray use in pregnant women are insufficient
optiray 350- ioversol injection optiray 320- ioversol injection optiray 300- ioversol injection
liebel-flarsheim company llc - ioversol (unii: n3rib7x24k) (ioversol - unii:n3rib7x24k) - optiray is indicated for: in adults - optiray 300: cerebral arteriography, and peripheral arteriography. - optiray 320: cerebral arteriography, peripheral arteriography, visceral and renal arteriography, aortography, coronary arteriography, and left ventriculography. - optiray 350: peripheral arteriography, coronary arteriography, and left ventriculography. in pediatric patients - optiray 320 and optiray 350: angiocardiography. in adults - optiray 300: ct imaging of the head and body, venography, and intravenous excretory urography. - optiray 320: ct imaging of the head and body, venography, and intravenous excretory urography. - optiray 350: ct imaging of the head and body, venography, intravenous excretory urography, and intravenous digital subtraction angiography (iv-dsa). in pediatric patients - optiray 320: ct imaging of the head and body, and intravenous excretory urography. symptomatic hyperthyroidism. risk summary postmarketing data with optiray use in pregnant women are insufficien
optiray 350 solution
liebel-flarsheim company llc - ioversol - solution - 74% - ioversol 74% - roentgenography
optiray 350 solution for infusion 100ml power injector pre-filled syringes
guerbet laboratories ltd - ioversol - solution for infusion - 350mg/1ml
optiray 350 solution for injection 30ml bottles
mallinckrodt uk commercial ltd - ioversol - solution for injection - 350mg/1ml